Access cutting-edge rheumatoid arthritis treatment through this clinical trial at a research site in Auburn. Study-provided care at no cost to qualified participants.
Access rheumatoid arthritis specialists in Auburn at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rheumatoid arthritis treatment provided free
The 2021 ACR RA treatment guideline, based on widely acknowledged low to moderate quality evidence, recommends switching to a non-tumor necrosis factor (TNFi) biologic (choose among existing medications, currently, rituximab, abatacept, tocilizumab, or sarilumab) or a targeted synthetic DMARD arm (tsDMARD; choose among existing medications, currently, tofacitinib, baricitinib, upadacitinib) in patients with active RA despite the use of a TNFi-biologic. In practice, most patients receive another
Sponsor: University of Alabama at Birmingham
Check if you qualify for this rheumatoid arthritis clinical trial in Auburn, AL
If you're searching for rheumatoid arthritis treatment options in Auburn, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Auburn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rheumatoid arthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.